James R. Merchant's Net Worth
$0
Estimate Recalculated Sep 8, 2024 07:30PM EST
Who is James R. Merchant?
James R. Merchant does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Anebulo Pharmaceuticals, Inc., and TS&W / CLAYMORE TAX-ADVANTAGED BALANCED FUND.
SEC CIK
James R. Merchant's CIK is 0001519923
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Anebulo Pharmaceuticals, Inc. (ANEB) Snapshot price: $2.38
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TS&W / CLAYMORE TAX-ADVANTAGED BALANCED FUND No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||